申请人:Roche Diagnostics GmbH
公开号:US06307051B1
公开(公告)日:2001-10-23
New compounds of formula I
wherein:
R and R1 are independently selected from hydrogen, (C1-C6)alkyl, styryl and (C3-C6)cycloalkyl or, taken together with the carbon to which they are linked, form a (C3-C6)cycloalkyl group;
A is selected from the following groups:
—CH2C≡CCH2—,
or —(CH2)q—NH—(CH2)q—,
wherein q is an integer from 2 to 3
B is selected from
T is selected from —CH2—C≡CH, —C≡CH, —(CH2)p—R3, —CH═CH—R3, —CH2—NHCO—R3, —(CH2)p—O—R3, —CH(NH2)—CH2R3, in which p is 0 or an integer from 1 to 4,
R3 is a carbocyclic or heterocyclic ring as medicaments having antitumor and/or antimetastatic activities.
公式I的新化合物,其中:R和R1独立地选自氢、(C1-C6)烷基、苯乙烯基和(C3-C6)环烷基,或者与它们相连的碳共同形成一个(C3-C6)环烷基团;A选自以下基团之一:—CH2C≡CCH2—,或—(CH2)q—NH—(CH2)q—,其中q是2到3之间的整数;B选自T选自—CH2—C≡CH,—C≡CH,—(CH2)p—R3,—CH═CH—R3,—CH2—NHCO—R3,—(CH2)p—O—R3,—CH(NH2)—CH2R3,其中p为0或1到4之间的整数,R3是具有抗肿瘤和/或抗转移活性的药物作为药用的大环或杂环。